Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that its subsidiary CannaCure Corp. (“CannaCure”) has been granted an amended sales license by Health Canada, effective April 12, 2021. This amended sales license allows Heritage to sell dried cannabis products, including flower and pre-rolls, directly to the provincial and territorial cannabis boards.
Heritage already offers extract and extract derivative products across Canada through their Pura Vida, Purefarma, RAD, Premium 5, and feelgood. brands, and with this amended license, will have the opportunity to address the largest category in terms of revenue in the Canadian cannabis market, topping 67% of total product sales in 2020. Beginning in May 2021, the Company will add dried cannabis products to the already expansive portfolio of products offered, beginning with the introduction of products under the popular RAD brand.
“Having the CannaCure sales license amended by Health Canada to sell dried cannabis is another accomplishment for the Heritage team and allows us to enter a high volume product category and deliver our newly developed SKUs to consumers across Canada through the provincial and territorial boards, as well as select on-line consumer platforms,” stated Clint Sharples, CEO of Heritage. “Our company continues to deliver innovative and sought-after products. This development is at the core of the Heritage story, and an expanded sales license offers us the flexibility to offer a breadth of high-quality, well-priced products that consumers are seeking across multiple product categories.”
About Heritage Cannabis Holdings Corp.
Heritage is a cannabinoid company focused on the production and sale of medical and recreational hemp-based and cannabis-based products and services. In Canada, Heritage operates through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these subsidiaries and the Purefarma, Pura Vida, RAD, Premium 5 and feelgood. brands, Heritage focuses on extraction and the creation of derivative products for recreational consumers, as well as the formulation of cannabis based medical solutions. In the U.S., Heritage operates under Opticann Inc., a Colorado based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb® drug delivery system for optimized absorption and stability. As the parent company, Heritage is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“Clint Sharples”
Clint Sharples
CEO
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005247/en/
Contacts
For more information:
Kelly Castledine
Tel: 647-660-2560
kcastledine@heritagecann.com
